Gene therapy for hemophilia: an imperative to succeed

This publication has 116 references indexed in Scilit:

• Factor IX variants improve gene therapy efficacy for hemophilia B
  Blood, 2005
• Side Effects Sideline Hemophilia Trial
  Science, 2004
• Sustained transgene expression by human cord blood derived CD34⁺ cells transduced with simian immunodeficiency virus agmTYO1‐based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice
  The Journal of Gene Medicine, 2004
• Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII
  Journal of Thrombosis and Haemostasis, 2003
• Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy
  Blood, 2003
• Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction
  Gene Therapy, 2003
• Bone marrow stromal cells as a genetic platformfor systemic delivery of therapeutic proteins in vivo: human factor IX model
  The Journal of Gene Medicine, 2002
• Site-specific genomic integration produces therapeutic Factor IX levels in mice
  Nature Biotechnology, 2002
• Expression of Biologically Active Human Factor IX in Human Hematopoietic Cells after Retroviral Vector-Mediated Gene Transduction
  Human Gene Therapy, 1995
• Liver Transplantation in a Hemophiliac
  New England Journal of Medicine, 1985